<DOC>
	<DOC>NCT01713504</DOC>
	<brief_summary>The purpose is to characterize new hypereosinophilic syndrome biomarkers more informative and more accessible compared to those that we have already thanks to a proteomic approach. This will help the investigators to diagnose the this disease.</brief_summary>
	<brief_title>Identification of New Markers in the Hypereosinophilic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypereosinophilic Syndrome</mesh_term>
	<criteria>dated and signed informed consent virale serology negative or negative result less than 6 months virale serology negative for HBV or vaccinated patient insured virale serology negative or negative result less than 6 months negative pregnancy test or female menopause for at least 1 year subject enable adult, under guardianship or under protective measures of justice Refusal or inability to give informed consent The hypereosinophilic syndrome explained origin other than than atopy, bullous pemphigoid, the ChurgStrauss syndrome and DRESS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>